Komori

Presentation Materials for the Second Quarter of the Fiscal Year Ending March 2027

Results presentationFirst half, FY ending Mar 2027Published 2026-11-17 12:00

For the second quarter of the fiscal year ending March 2027, revenue, operating profit and net income increased substantially, driven by the consolidation of 森六ReNova and higher production in North America. The full-year forecasts for revenue and profit were also revised upward to reflect the first-half upside, among other factors.

In short

Forecast raised
  • Revenue increased 53.9% year on year to ¥102.0 billion, driven by the consolidation of 森六ReNova and higher production in North America.
  • Operating profit increased 210.3% year on year to ¥5.6 billion, and the operating margin improved to 5.5%.
  • Reflecting the first-half upside, among other factors, the full-year operating profit forecast was raised from ¥6.5 billion to ¥8.0 billion.

What they reported

this period against the same period a year earlier, and where they now expect the year to end

Sales

¥102.0bn+53.9%vs a year earlier
H1 FY26¥66.3bnH1 FY27¥102.0bn
FY25FY26FY27 · this year304050¥bnQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4+42%+66%this yearvs same quarter last yearnew forecast48.3 a quarterold forecast46.3 a quarterlast year
Sales by quarter
Period¥bn
FY25 Q136.3
FY25 Q235.4
FY25 Q336.3
FY25 Q438.2
FY26 Q133.8
FY26 Q232.5
FY26 Q331.2
FY26 Q436.4
FY27 Q148.2
FY27 Q253.8
last year 133.9
was 194.6
now 198.7
Full-year forecast, ¥bn+2.1% vs the old forecast
Old and new forecast from the company's results releases
Why

Revenue increased, driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business.

売上高・営業利益:森六ReNovaの連結効果、北米の増産、ケミカル事業の販売増・価格改定効果等により、増収増益
Revenue and operating profit: increased revenue and profit driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business, among other factors

Operating profit

¥5.6bn+210.4%vs a year earlier
H1 FY26¥1.8bnH1 FY27¥5.6bn
FY25FY26FY27 · this year02¥bnQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4+113%+351%this yearvs same quarter last yearlast yearnew forecast1.2 a quarterold forecast0.4 a quarter
Operating profit by quarter
Period¥bn
FY25 Q11.4
FY25 Q20.2
FY25 Q30.3
FY25 Q42.2
FY26 Q11.1
FY26 Q20.7
FY26 Q30.2
FY26 Q42.6
FY27 Q12.3
FY27 Q23.3
last year 4.6
was 6.5
now 8.0
Full-year forecast, ¥bn+23.1% vs the old forecast
Old and new forecast from the company's results releases
Why

Profit increased, driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business.

売上高・営業利益:森六ReNovaの連結効果、北米の増産、ケミカル事業の販売増・価格改定効果等により、増収増益
Revenue and operating profit: increased revenue and profit driven by the consolidation of 森六ReNova, higher production in North America, and increased sales and the effects of price revisions in the Chemicals business, among other factors

Ordinary profit

¥5.2bn+225.4%vs a year earlier
H1 FY26¥1.6bnH1 FY27¥5.2bn
FY25FY26FY27 · this year02¥bnQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4+154%+319%this yearvs same quarter last yearlast yearnew forecast1.0 a quarter
Ordinary profit by quarter
Period¥bn
FY25 Q11.6
FY25 Q2-1.0
FY25 Q30.2
FY25 Q41.4
FY26 Q10.9
FY26 Q20.7
FY26 Q30.3
FY26 Q42.1
FY27 Q12.3
FY27 Q22.9
last year 4.0
now 7.3
Full-year forecast, ¥bnthe first forecast for this year
Forecast from this deck (no earlier forecast on record)

Net profit

¥5.8bn+501.1%vs a year earlier
H1 FY26¥1.0bnH1 FY27¥5.8bn
FY25FY26FY27 · this year-505¥bnQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4+561%+427%this yearvs same quarter last yearlast yearnew forecast-0.1 a quarterold forecast-0.2 a quarter
Net profit by quarter
Period¥bn
FY25 Q11.5
FY25 Q2-1.3
FY25 Q3-0.1
FY25 Q4-7.9
FY26 Q10.5
FY26 Q20.4
FY26 Q3-0.1
FY26 Q41.6
FY27 Q13.5
FY27 Q22.3
last year 2.4
was 5.4
now 5.6
Full-year forecast, ¥bn+3.7% vs the old forecast
Old and new forecast from the company's results releases
Why

A ¥2.1 billion gain on bargain purchase arising from M&A was recorded as extraordinary income.

中間純利益: M&Aに伴い、負ののれん発生益21億円を特別利益として計上
Interim net income: a ¥2.1 billion gain on bargain purchase arising from M&A was recorded as extraordinary income

Dividend

cash paid per share for the year, and how much of profit that is
¥125unchangedper share
old plan¥125FY27 plan¥125
32.0% of profit paid as dividends

Payout worked out from the FY27 forecast dividend and forecast EPS.

The company will steadily raise dividend levels, targeting a DOE of 3% or higher in the fiscal year ending March 2028.

Their own numbers

figures this company chose to report, a year ago against now
Operating profit margin
5.5 % · a year ago 2.7 %

The operating margin improved from 2.7% in the same period of the previous year to 5.5%.

PBR
0.5 xFY26 · FY25 0.5 x

Although PBR is trending upward, it remains below the target of 1.0x.

ROE
8.1 %FY27 plan · FY26 3.8 %

ROE for the fiscal year ending March 2027 is expected to rise temporarily due to the gain on bargain purchase arising from M&A.

The low–high ranges are Komori's estimate, not figures the company gave.

Everything else in the deck

By business

bar = share of sales · rows = operating profit and change vs a year earlier
Resin processing products business 87%
sales ¥88.9bn +65.0%
profit ¥5.1bn +149.0%
Chemicals Business 13%
sales ¥13.0bn +5.5%
profit ¥1.3bn +116.5%

What moved

change vs a year earlier, by the company's own breakdown
Operating profit of the Resin Processing Products business
森六ReNova business+¥1.7bn
Production fluctuations and mold transactions−¥0.3bn
Impact of inflation+¥0.2bn
Cost improvement+¥0.6bn
Other+¥0.9bn
Operating profit of the Chemicals business
Change in net sales+¥0.2bn
Change in gross profit+¥0.4bn
Change in SG&A+¥0.1bn
Bar colour is the direction of the amount (red = up, teal = down).

New initiatives

what they said they're starting
  • The company will acquire 3 companies, including 森六ReNova, and integrate their technologies in decoration, electrical systems and weight reduction with technologies in exterior foaming and modularization.
  • The company will establish NAMO Chemical, a joint venture with a South Korean company, to develop and manufacture auxiliary materials that prevent lithium-ion batteries from catching fire.
  • The company will leverage 四国化工's high-value-added film technology to develop the medical and packaging materials fields in India and ASEAN.
  • The company will transfer all of its interest in 广州森六 and pursue the optimization of its operations in China and the selective allocation and concentration of management resources.

Investment in equipment

capital spending for the year
¥26.9bnFY27 plan

planned for the year. The deck doesn't say how much is spent so far.

Buying back its own shares

the other way to return cash, besides dividends
Only under consideration

The company will also respond flexibly to the acquisition and cancellation of treasury shares.

What decks usually leave out

COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deck

Progress toward the full-year forecast

share of the year's target already earned, against the same point in past years
Computed
70%of the operating profit forecast earned
with 50% of the year gone: ahead of every one of the last 3 years at this point
50% of the year gone
FY24
18%
FY25
39%
FY26
39%
FY27
70%
how much of the year has gonepast-year average at this point (32%)

¥5.6bn earned of the ¥8.0bn forecast. Against the old forecast (¥6.5bn) it would be 87%.

The rest of the year has to bring in ¥2.4bn, +38 pts off the usual pace.

Progress toward the full-year forecast
Period%
FY2418%
FY2539%
FY2639%
FY2770%

Margins and overheads

where each ¥100 of sales goes
Computed
a year ago2.7%now5.5%

Financial targets

the last five years against the target (green band), where one is stated
Computed
Return on equity7.4%
profit earned on shareholders' money
2035: 10% or higher
2.6 pts away, getting closer
-13%0%12%targetFY22FY23FY24FY25FY26FY27FY22: 6.0%FY23: 1.9%FY24: 4.1%FY25: -11.1%FY26: 3.7%FY27: 7.4% (forecast)7.4%
Return on equity
Period%
FY226.0
FY231.9
FY244.1
FY25-11.1
FY263.7
FY277.4
Equity ratio41.9%
how much of the balance sheet is owned outright
−11.6 pts on last year
40%48%55%FY22FY23FY24FY25FY26FY27FY22: 51.6%FY23: 52.6%FY24: 53.4%FY25: 51.1%FY26: 53.5%FY27: 41.9%41.9%
Equity ratio
Period%
FY2251.6
FY2352.6
FY2453.4
FY2551.1
FY2653.5
FY2741.9
Payout ratio32.0%
share of profit paid as dividends
−35.3 pts on last year
30%74%118%FY22FY23FY24FY26FY27FY22: 36.3%FY23: 115.8%FY24: 49.8%FY26: 67.3%FY27: 32.0% (forecast)32.0%
Payout ratio
Period%
FY2236.3
FY23115.8
FY2449.8
FY2667.3
FY2732.0
DOE
DOE of 3% or higher in the fiscal year ending March 2028
3% or more

Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.

How they rate themselves against plan

the company's own grade for the period, next to the numbers
What they said
Mixed against plan

Performance was generally in line with plan in regions outside China, but below plan in China.

中国以外の地域では、概ね計画どおりに推移
Performance was generally in line with plan in regions outside China

Assumptions behind the forecast

what they expect for the rest of the year, against what's happened so far
U.S. dollar exchange rate
assumed 150 ¥ · so far 159.5 ¥
so far
assumed
Chinese yuan exchange rate
assumed 22.1 ¥ · so far 23.5 ¥
so far
assumed

Mid-term plan targets

14th Medium-Term Management Plan and Growth Strategy · to 2035
ROE203510%
Consolidated net sales2035¥220.0bn
North American operating margin20356%
Revenue contribution from growth fields203520%
Overseas revenue ratio203550%
Integration Synergies2035¥1.5bn
DOEFiscal year ending March 20283%

Not mentioned in this deck

7
Risks priced into the forecastOrders and backlogPrice and volumeStore or site countHeadcountMarket size and shareInvestor Q&A